Chris Twelves

Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy

Geoff Hall, Jose Leal, Karl Baker, 2017, Int. J. Medical Informatics.

Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients

John M S Bartlett, David Cameron, Chris Twelves, 2009, Clinical Cancer Research.

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.

David Miles, Shailendra Verma, Chris Twelves, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: a dose-escalation study.

Rob Jones, Chris Twelves, J. Baselga, 2008, European journal of cancer.

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Chris Twelves, Fatima Cardoso, T. Delozier, 2011, The Lancet.

Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.

Andreas Schätzlein, Chris Twelves, Carol McCormick, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer.

Daniel J Sargent, Greg Yothers, Lindsay A Renfro, 2014, Journal of the National Cancer Institute.

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study.

Chris Twelves, A. Ravaud, J. Wanders, 2005, European journal of cancer.

Capecitabine as adjuvant treatment for stage III colon cancer.

Markus Abt, Joseph McKendrick, Marek Pawlicki, 2005, The New England journal of medicine.